|
ATCC
human primary macrophages human primary peripheral blood mononuclear cells Human Primary Macrophages Human Primary Peripheral Blood Mononuclear Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+blood/Primary+Peripheral+Blood+CD14%2B+Monocytes%2C+Normal%2C+Human/pm42886558-295-2-12 Average 99 stars, based on 1 article reviews
human primary macrophages human primary peripheral blood mononuclear cells - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
MedChemExpress
myeloperoxidase Myeloperoxidase, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+blood/Myeloperoxidase%2C+human+white+blood+cells/pm42810343-285-45-50 Average 94 stars, based on 1 article reviews
myeloperoxidase - by Bioz Stars,
2026-10
94/100 stars
|
Buy from Supplier |
|
ATCC
primary peripheral blood mononuclear cells pbmc normal human Primary Peripheral Blood Mononuclear Cells Pbmc Normal Human, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+blood/Primary+Peripheral+Blood+Mononuclear+Cells+(PBMC)%2C+Normal%2C+Human/pm42886558-277-120-128 Average 99 stars, based on 1 article reviews
primary peripheral blood mononuclear cells pbmc normal human - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
Beijing Solarbio Science
peripheral venous blood Peripheral Venous Blood, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+blood/Human+Peripheral+Blood+Lymphocyte+Isolation+Solution/pm42886791-315-6-16 Average 95 stars, based on 1 article reviews
peripheral venous blood - by Bioz Stars,
2026-10
95/100 stars
|
Buy from Supplier |
|
Cedarlane
lympholyte poly Lympholyte Poly, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+blood/Lympholyte%C2%AE-poly+Cell+Separation+Media+(Isolation+of+PMNs+from+Human+peripheral+blood)%2C+1%2E113+%C2%B1+0%2E001+g%2Fml+%4025%C2%B0C/pm42867249-132-7-8 Average 93 stars, based on 1 article reviews
lympholyte poly - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
Beijing Solarbio Science
human peripheral blood lymphocyte separation medium Human Peripheral Blood Lymphocyte Separation Medium, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+blood/Lymphocyte+Separation+Medium/pm42852629-60-0-6 Average 96 stars, based on 1 article reviews
human peripheral blood lymphocyte separation medium - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
|
ATCC
peripheral blood mononuclear cells Peripheral Blood Mononuclear Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+blood/Primary+Peripheral+Blood+Mononuclear+Cells+(PBMC)%2C+Normal%2C+Human/pm42837351-57-9-18 Average 99 stars, based on 1 article reviews
peripheral blood mononuclear cells - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
Innovative Research Inc
heat inactivated human blood type ab serum Heat Inactivated Human Blood Type Ab Serum, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+blood/Pooled+Human+AB+Serum+Plasma+Derived+Heat+Inactivated/pm42836482-24-25-33 Average 93 stars, based on 1 article reviews
heat inactivated human blood type ab serum - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
Streck Laboratories
cd chex plus stabilized human blood ![]() Cd Chex Plus Stabilized Human Blood, supplied by Streck Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+blood/CD-Chex+Plus/pmc13677906-47-0-12 Average 94 stars, based on 1 article reviews
cd chex plus stabilized human blood - by Bioz Stars,
2026-10
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
human macsxpress whole blood neutrophil isolation kit ![]() Human Macsxpress Whole Blood Neutrophil Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+blood/MACSxpress+Whole+Blood+Neutrophil+Isolation+Kit%2C+human/10__1038_slash_s41598___026___70767___0-195-7-14 Average 96 stars, based on 1 article reviews
human macsxpress whole blood neutrophil isolation kit - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
Journal: Frontiers in Immunology
Article Title: An optimized spectral flow cytometry pipeline for longitudinal blood leukocyte immunophenotyping reveals stable, individually distinct immune signatures
doi: 10.3389/fimmu.2026.1959895
Figure Lengend Snippet: Comparison of PaCMAP-based and traditional 2D biaxial gating consistency for leukocyte subset identification. CD-CHEX–stabilised blood from two donors (different lots; CD1 and CD2) was gated across up to four experimental timepoints by three independent expert operators using either traditional 2D hierarchical biaxial gating (purple) or PaCMAP dimensionality-reduction-based gating (green). Gating purity was assessed against UMAP-defined reference gates drawn by a single expert. (A) Longitudinal trajectories of correct-assignment percentages (% cells landing in the corresponding UMAP reference gate) across timepoints (Vo1 to Vo4), faceted by population (columns); the two donors are distinguished within each facet by point shape (circle, triangle) and mean-line style (solid, long-dashed). Each bold line links the per-donor mean at each timepoint (filled points, colored by method); dotted light lines are individual operator trajectories (largely overlapping and difficult to discern for PaCMAP). The y-axis is pseudo-log-scaled to resolve values near 100% (using scales::pseudo_log_trans(sigma = 0.1) in R). (B) Boxplots of correct-assignment percentages per population; boxes show the interquartile range (IQR), whiskers extend to 1.5 × IQR, white diamonds mark the group mean, and dots are individual operator × timepoint observations, colored by method and shaped by donor. (C) Boxplots of contamination percentages (% cells from a gated population landing in a non-corresponding UMAP reference gate) faceted by UMAP gated population, on a pseudo-log axis to accommodate the many zero values; boxes and dots as in (B) , with donor shown by point shape. (D) Summary of Wilcoxon rank-sum comparisons (Benjamini–Hochberg-adjusted) between methods across six metrics: correct-assignment temporal stability (SD), correct-assignment inter-rater ICC, mean contamination, proportion of zero-contamination events, contamination temporal stability (SD) and contamination inter-rater ICC; columns give each method’s group mean, the adjusted p-value and the direction; cell color indicates the significant direction (green, PaCMAP superior; orange, 2D superior; white, p ≥ 0.05). ICC (intraclass correlation coefficient) was computed with a two-way model, absolute agreement, single unit (irr::icc); groups with undefined between-operator variance were excluded as degenerate (fewer than two timepoints or three raters, or near-zero overall variance [SD < 0.01]; groups with identical values across raters were treated as perfect agreement), leaving n = 15 (PaCMAP) and n = 16 (2D) for correct assignment. Temporal-stability SD, mean contamination and the zero-contamination proportion were computed per operator and then compared between methods, isolating within-operator consistency; ICC uses the three operators as raters and therefore quantifies between-operator agreement.
Article Snippet:
Techniques: Comparison, Stability, Immunocytochemistry
Journal: Frontiers in Immunology
Article Title: An optimized spectral flow cytometry pipeline for longitudinal blood leukocyte immunophenotyping reveals stable, individually distinct immune signatures
doi: 10.3389/fimmu.2026.1959895
Figure Lengend Snippet: Pre-analytical handling effects on leukocyte composition and two-tier normalization. Whole blood from healthy donors was processed under varying pre-analytical conditions (n = 3 replicates per condition) and immunophenotyped by flow cytometry; populations are expressed as a percentage of total leukocytes. (A–D) Mean leukocyte subset composition (stacked bars: neutrophils, monocytes/macrophages/dendritic cells, eosinophils, B cells, T cells) per condition, with the five-population Bray–Curtis PERMANOVA result above each panel: (A) refrigerated storage at 4°C for 1, 2 or 3 days (Day 1 fresh reference; samples were pooled then split from donor 1, 4, and 6); (B) cryopreservation in CryoStor CS10 or DMSO for 15 days versus fresh (samples were split from donor 4); (C) chemical fixation analyzed at Day 1 or Day 5 versus unfixed Day 1 (samples were split from donor 4); (D) one-week-stored versus freshly prepared antibody cocktail (samples were split from donor 4). Companion data of numerical mean values in . (E–H) Two sequential leukocyte count normalization tiers were compared against raw counts for longitudinal stability. Tier 1 rescaled within-sample (to CD45 + % [%CD45], or to cells/mL by counting beads [bead] or volume [vol]); Tier 2 added a CD-CHEX-anchored cross-batch correction to remove run-to-run drift (schemes detailed in ): (E) Lineage populations of CD-CHEX, including eight major lineage populations (as described in ), were assessed for count stability over time (y-axis, Bray–Curtis dissimilarity to the first timepoint per tier, x-axis, acquisition month; lower and flatter = more stable). Each line is one normalization scheme (color) for one held-out CD-CHEX lot (line style and point shape distinguish the two lots, CHEX 3268 and CHEX 5069), with raw counts (raw) shown in every facet as a common reference; facets are the three Tier families (%CD45, bead, vol). The dashed line marks a dissimilarity of 0.1 for reference. (F) Posterior contrasts of CD-CHEX lineage count stability for each scheme versus raw counts (model below). (G) Longitudinal stability of lineage and subpopulation counts from fresh blood of 10 donors (populations as in ). X-axis, visit in chronological order; y-axis, mean Bray–Curtis dissimilarity to the first visit across donors, with the shaded ribbon the standard error across donors; each line is one scheme (color), raw counts repeated in each facet as reference; facets are level (lineages, subpopulations) × Tier family. (H) Corresponding posterior contrasts versus raw counts. In (F, H) , Bray–Curtis dissimilarity to the reference timepoint was modelled by Beta regression (brms) with normalization scheme as a fixed effect and a random intercept per population group (CD-CHEX lot in F; donor in H). Points are the posterior median difference from raw counts (ΔBray–Curtis) and bars the 80% (thick) or 95% (thin) credible interval (CI); negative values indicate greater stability than raw. A scheme was classed as more stable (green) or less stable (orange) than raw when its 95% CI excluded zero, and equivalent (gray) when it included zero. P denotes the posterior probability that a scheme has lower temporal dissimilarity than raw (the proportion of posterior draws with ΔBray–Curtis < 0), such that P = 1.00 indicates every draw favored greater stability. All models converged well (Rˆ ≤ 1.01, no divergent transitions); model convergence and fit diagnostics are given in .
Article Snippet:
Techniques: Flow Cytometry, Stability, Counting